ERSP finds claims unsupported
This article was originally published in The Tan Sheet
Intelligent Beauty Inc. voluntarily discontinues marketing claims that a percent of consumers who used its iQ Clear Remedy Acne System saw no new breakouts, reported clear skin or saw results in three days, according to the Electronic Retailing Self-Regulation Program administered by the Council for Better Business Bureaus. ERSP reviewed the Manhattan Beach, Calif.-based marketer's advertising as part of its standard monitoring activities. The group also recommended Intelligent Beauty discontinue use of before and after images online that purportedly show the product's results after three days of use, according to a Dec. 29 release. ERSP says the marketer supported the claim "clinically tested and proven to work.
You may also be interested in...
The independent, family-controlled German group has signed a third R&D pact with Danish biotech Gubra to develop poly-agonist peptides for obesity.
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.